BIOMAT Database Logo BIOMAT Database Logo

[Immunosuppressive therapy of ulcerative colitis]. 1972

L Szántó, and K Teleki

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011033 Podophyllin Caustic extract from the roots of Podophyllum peltatum and P. emodi. It contains PODOPHYLLOTOXIN and its congeners and is very irritating to mucous membranes and skin. Podophyllin is a violent purgative that may cause CNS damage and teratogenesis. It is used as a paint for warts, skin neoplasms, and senile keratoses. Podophyllum Resin,Resin, Podophyllum
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D005260 Female Females
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine

Related Publications

L Szántó, and K Teleki
Immunosuppressive therapy in ulcerative colitis.
May 1969, Proceedings of the Royal Society of Medicine,
L Szántó, and K Teleki
[Ulcerative colitis and immunosuppressive therapy].
January 1971, Medicinski glasnik,
L Szántó, and K Teleki
Immunosuppressive therapy for ulcerative colitis, ileitis, and granulomatous colitis.
August 1972, The Surgical clinics of North America,
L Szántó, and K Teleki
Immunosuppressive and biologic therapy for ulcerative colitis.
December 2012, Expert opinion on emerging drugs,
L Szántó, and K Teleki
[Recommendations for immunosuppressive therapy in ulcerative colitis].
June 1972, Monatsschrift fur Kinderheilkunde,
L Szántó, and K Teleki
[Immunosuppressive therapy of ulcerative colitis and Crohn's disease].
January 1973, Das Deutsche Gesundheitswesen,
L Szántó, and K Teleki
Experiences with immunosuppressive therapy in childhood ulcerative colitis.
January 1971, Zeitschrift fur Kinderheilkunde,
L Szántó, and K Teleki
[Immunosuppressive treatment of ulcerative colitis].
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
L Szántó, and K Teleki
[Basis of the immunosuppressive therapy of ulcerative colitis in childhood].
June 1972, Monatsschrift fur Kinderheilkunde,
L Szántó, and K Teleki
[Triple immunosuppressive therapy in the treatment of severe ulcerative colitis].
January 2004, Gastroenterologia y hepatologia,
Copied contents to your clipboard!